AXL and cancer: Given that the downstream mTOR pathway inhibition can be associated with (Z)-BP-inactivated receptor tyrosine kinase including Axl [32,33], several cancer pathways are blocked [34,35], and a synergistic effect with TMZ is then achieved [36,37].